Annual EBITDA
-$69.75 M
+$126.71 M+64.49%
December 31, 2024
Summary
- As of March 14, 2025, TNDM annual EBITDA is -$69.75 million, with the most recent change of +$126.71 million (+64.49%) on December 31, 2024.
- During the last 3 years, TNDM annual EBITDA has fallen by -$103.81 million (-304.80%).
- TNDM annual EBITDA is now -304.80% below its all-time high of $34.06 million, reached on December 31, 2021.
Performance
TNDM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$4.21 M
+$20.75 M+125.49%
December 31, 2024
Summary
- As of March 14, 2025, TNDM quarterly EBITDA is $4.21 million, with the most recent change of +$20.75 million (+125.49%) on December 31, 2024.
- Over the past year, TNDM quarterly EBITDA has increased by +$29.78 million (+116.49%).
- TNDM quarterly EBITDA is now -83.13% below its all-time high of $24.99 million, reached on December 31, 2020.
Performance
TNDM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$70.22 M
+$29.78 M+29.78%
December 31, 2024
Summary
- As of March 14, 2025, TNDM TTM EBITDA is -$70.22 million, with the most recent change of +$29.78 million (+29.78%) on December 31, 2024.
- Over the past year, TNDM TTM EBITDA has increased by +$125.68 million (+64.15%).
- TNDM TTM EBITDA is now -262.15% below its all-time high of $43.31 million, reached on September 30, 2021.
Performance
TNDM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TNDM EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +64.5% | +116.5% | +64.2% |
| 3 y3 years | -304.8% | +137.0% | +5.4% |
| 5 y5 years | -276.4% | +137.0% | +5.4% |
TNDM EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -304.8% | +64.5% | -73.2% | +103.5% | -306.2% | +65.2% |
| 5 y | 5-year | -304.8% | +64.5% | -83.1% | +103.5% | -262.1% | +65.2% |
| alltime | all time | -304.8% | +64.5% | -83.1% | +103.5% | -262.1% | +65.2% |
Tandem Diabetes Care EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$69.75 M(-64.5%) | $4.21 M(-125.5%) | -$70.22 M(-29.8%) |
| Sep 2024 | - | -$16.54 M(-30.6%) | -$100.00 M(-5.7%) |
| Jun 2024 | - | -$23.84 M(-30.0%) | -$106.03 M(-4.4%) |
| Mar 2024 | - | -$34.06 M(+33.2%) | -$110.95 M(-43.4%) |
| Dec 2023 | -$196.46 M(+164.7%) | -$25.57 M(+13.3%) | -$195.90 M(+7.8%) |
| Sep 2023 | - | -$22.57 M(-21.5%) | -$181.72 M(-10.0%) |
| Jun 2023 | - | -$28.76 M(-75.8%) | -$201.92 M(+11.3%) |
| Mar 2023 | - | -$119.00 M(+944.4%) | -$181.48 M(+144.6%) |
| Dec 2022 | -$74.21 M(-317.9%) | -$11.39 M(-73.4%) | -$74.21 M(+57.7%) |
| Sep 2022 | - | -$42.76 M(+414.0%) | -$47.07 M(-882.2%) |
| Jun 2022 | - | -$8.32 M(-29.1%) | $6.02 M(-73.7%) |
| Mar 2022 | - | -$11.73 M(-174.5%) | $22.92 M(-32.7%) |
| Dec 2021 | $34.06 M(-349.0%) | $15.74 M(+52.5%) | $34.06 M(-21.4%) |
| Sep 2021 | - | $10.33 M(+20.3%) | $43.31 M(+38.8%) |
| Jun 2021 | - | $8.59 M(-1536.0%) | $31.21 M(-2436.2%) |
| Mar 2021 | - | -$598.00 K(-102.4%) | -$1.34 M(-90.2%) |
| Dec 2020 | -$13.68 M(-26.2%) | $24.99 M(-1512.7%) | -$13.68 M(-60.1%) |
| Sep 2020 | - | -$1.77 M(-92.6%) | -$34.30 M(+1.3%) |
| Jun 2020 | - | -$23.96 M(+85.2%) | -$33.87 M(+241.9%) |
| Mar 2020 | - | -$12.94 M(-396.0%) | -$9.91 M(-46.5%) |
| Dec 2019 | -$18.53 M(-83.0%) | $4.37 M(-425.0%) | -$18.52 M(+4.6%) |
| Sep 2019 | - | -$1.34 M(<-9900.0%) | -$17.70 M(-62.9%) |
| Jun 2019 | - | $5000.00(-100.0%) | -$47.75 M(-53.5%) |
| Mar 2019 | - | -$21.55 M(-515.7%) | -$102.60 M(-6.0%) |
| Dec 2018 | -$109.18 M | $5.18 M(-116.5%) | -$109.18 M(-9.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$31.39 M(-42.8%) | -$120.73 M(+19.9%) |
| Jun 2018 | - | -$54.84 M(+95.0%) | -$100.73 M(+59.4%) |
| Mar 2018 | - | -$28.13 M(+341.4%) | -$63.21 M(+15.3%) |
| Dec 2017 | -$54.82 M(-24.1%) | -$6.37 M(-44.0%) | -$54.82 M(-9.1%) |
| Sep 2017 | - | -$11.39 M(-34.3%) | -$60.28 M(-20.7%) |
| Jun 2017 | - | -$17.32 M(-12.3%) | -$75.98 M(+2.4%) |
| Mar 2017 | - | -$19.74 M(+66.8%) | -$74.22 M(+2.7%) |
| Dec 2016 | -$72.27 M(+13.2%) | -$11.84 M(-56.3%) | -$72.27 M(+2.7%) |
| Sep 2016 | - | -$27.08 M(+74.0%) | -$70.34 M(+15.9%) |
| Jun 2016 | - | -$15.56 M(-12.5%) | -$60.68 M(-2.9%) |
| Mar 2016 | - | -$17.79 M(+79.5%) | -$62.49 M(-2.1%) |
| Dec 2015 | -$63.84 M(-10.3%) | -$9.91 M(-43.1%) | -$63.84 M(-8.9%) |
| Sep 2015 | - | -$17.42 M(+0.2%) | -$70.09 M(-0.6%) |
| Jun 2015 | - | -$17.38 M(-9.2%) | -$70.48 M(+0.1%) |
| Mar 2015 | - | -$19.13 M(+18.3%) | -$70.39 M(-1.1%) |
| Dec 2014 | -$71.16 M(+28.8%) | -$16.17 M(-9.2%) | -$71.16 M(-7.3%) |
| Sep 2014 | - | -$17.81 M(+3.0%) | -$76.74 M(+9.6%) |
| Jun 2014 | - | -$17.29 M(-13.1%) | -$70.03 M(+6.2%) |
| Mar 2014 | - | -$19.90 M(-8.5%) | -$65.95 M(+19.3%) |
| Dec 2013 | -$55.26 M(+94.2%) | -$21.74 M(+95.9%) | -$55.26 M(+34.0%) |
| Sep 2013 | - | -$11.10 M(-16.0%) | -$41.23 M(+14.6%) |
| Jun 2013 | - | -$13.21 M(+43.4%) | -$35.97 M(+58.0%) |
| Mar 2013 | - | -$9.21 M(+19.5%) | -$22.76 M(+68.0%) |
| Dec 2012 | -$28.46 M(+20.1%) | -$7.71 M(+31.9%) | -$13.55 M(+131.9%) |
| Sep 2012 | - | -$5.84 M | -$5.84 M |
| Dec 2011 | -$23.69 M | - | - |
FAQ
- What is Tandem Diabetes Care annual EBITDA?
- What is the all time high annual EBITDA for Tandem Diabetes Care?
- What is Tandem Diabetes Care annual EBITDA year-on-year change?
- What is Tandem Diabetes Care quarterly EBITDA?
- What is the all time high quarterly EBITDA for Tandem Diabetes Care?
- What is Tandem Diabetes Care quarterly EBITDA year-on-year change?
- What is Tandem Diabetes Care TTM EBITDA?
- What is the all time high TTM EBITDA for Tandem Diabetes Care?
- What is Tandem Diabetes Care TTM EBITDA year-on-year change?
What is Tandem Diabetes Care annual EBITDA?
The current annual EBITDA of TNDM is -$69.75 M
What is the all time high annual EBITDA for Tandem Diabetes Care?
Tandem Diabetes Care all-time high annual EBITDA is $34.06 M
What is Tandem Diabetes Care annual EBITDA year-on-year change?
Over the past year, TNDM annual EBITDA has changed by +$126.71 M (+64.49%)
What is Tandem Diabetes Care quarterly EBITDA?
The current quarterly EBITDA of TNDM is $4.21 M
What is the all time high quarterly EBITDA for Tandem Diabetes Care?
Tandem Diabetes Care all-time high quarterly EBITDA is $24.99 M
What is Tandem Diabetes Care quarterly EBITDA year-on-year change?
Over the past year, TNDM quarterly EBITDA has changed by +$29.78 M (+116.49%)
What is Tandem Diabetes Care TTM EBITDA?
The current TTM EBITDA of TNDM is -$70.22 M
What is the all time high TTM EBITDA for Tandem Diabetes Care?
Tandem Diabetes Care all-time high TTM EBITDA is $43.31 M
What is Tandem Diabetes Care TTM EBITDA year-on-year change?
Over the past year, TNDM TTM EBITDA has changed by +$125.68 M (+64.15%)